Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-044540
Filing Date
2024-10-31
Accepted
2024-10-31 16:00:43
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdcx-20240930.htm   iXBRL 10-Q 1525543
2 EX-10.2 ex-102wrgracecotenthamendm.htm EX-10.2 21812
3 EX-31.1 cdxcex-311q32024.htm EX-31.1 10558
4 EX-31.2 cdxcex-312q32024.htm EX-31.2 10506
5 EX-32.1 cdxcex-321q32024.htm EX-32.1 5747
11 GRAPHIC cdcx-20240930_g1.jpg GRAPHIC 26428
  Complete submission text file 0001628280-24-044540.txt   7584813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdcx-20240930.xsd EX-101.SCH 47158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdcx-20240930_cal.xml EX-101.CAL 54853
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdcx-20240930_def.xml EX-101.DEF 223339
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdcx-20240930_lab.xml EX-101.LAB 580581
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdcx-20240930_pre.xml EX-101.PRE 401527
79 EXTRACTED XBRL INSTANCE DOCUMENT cdcx-20240930_htm.xml XML 1281385
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37752 | Film No.: 241415117
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)